At a glance
- Originator Johnson & Johnson
- Class Anti-inflammatories; Antirheumatics; Small molecules
- Mechanism of Action Intercellular adhesion molecule-1 antagonists; Lymphocyte function-associated antigen-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 09 Mar 1999 No-Development-Reported for Rheumatoid arthritis in USA (Unknown route)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Rheumatoid arthritis in USA (Unknown route)